24
Participants
Start Date
June 30, 2016
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2016
Cabotegravir 30 mg
Cabotegravir (GSK1265744B ) is available as white to almost white, oval shaped, film coated tablet, of weight 515 mg. The tablet contains micronized cabotegravir, lactose monohydrate, microcrystalline cellulose, hypromellose, sodium starch glycolate, and magnesium stearate. Each tablet is equivalent to 30 mg cabotegravir and needs to be taken orally with 240 mL of water. Cabotegravir tablet will be administered to subjects either in fasting condition or following a high fat meal.
GSK Investigational Site, Overland Park
Lead Sponsor
Glaxosmithkline/Quintiles
UNKNOWN
ViiV Healthcare
INDUSTRY